Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Current students: Log in to Scholarship Universe by using your career account and password. Incoming students: Log in to Scholarship Universe through the admissions portal. The left-hand side of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback